PLAC test for identification of individuals at increased risk for coronary heart disease.
about
Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemiaPredicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?The elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of apoB/Lp-PLA₂.Unraveling the PAF-AH/Lp-PLA2 controversy.
P2860
PLAC test for identification of individuals at increased risk for coronary heart disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
PLAC test for identification of individuals at increased risk for coronary heart disease.
@ast
PLAC test for identification of individuals at increased risk for coronary heart disease.
@en
type
label
PLAC test for identification of individuals at increased risk for coronary heart disease.
@ast
PLAC test for identification of individuals at increased risk for coronary heart disease.
@en
prefLabel
PLAC test for identification of individuals at increased risk for coronary heart disease.
@ast
PLAC test for identification of individuals at increased risk for coronary heart disease.
@en
P2860
P356
P1476
PLAC test for identification of individuals at increased risk for coronary heart disease
@en
P2093
Christie M Ballantyne
P2860
P356
10.1586/14737159.5.1.9
P577
2005-01-01T00:00:00Z